Orphanet: Einfache Suche

Suche klinische Studie

Weitere Suchoptionen

50 Ergebnis(se)

Nationale klinische Studie(n)

An open-label, prospective, single-centre, phase II study to assess dose and dose interval requirements with respect to efficacy and safety of AOP2014, PEG-Proline-Interferon alpha-2b, in patients with primary myelofibrosis (grade MF-0 and MF-1) Medizinische Universität Wien

MEMMAT: A Phase II study of metronomic and targeted anti-angiogenesis therapy for children with recurrent/progressive medulloblastoma - AT Medizinische Universität Wien

Immunomodulation of Pembrolizumab Plus Docetaxel for the Treatment of Recurrent or Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (HNSCC) After Platinum Failure (Phase I-II) Medizinische Universität Wien

O-MA 1: A Phase II trial of Ofatumumab in patients with lymphoma of the of the mucosa associated lymphoid tissue (MALT-Lymphoma) Medizinische Universität Wien

Characterization of Humoral and Cellular Immunity for Tick-borne Encephalitis (TBE) Vaccination in Allogeneic Blood and Marrow Graft Recipients: a Pilot Study Medizinische Universität Wien

MALT-A 1: A phase II trial of long-term treatment with azithromycin in patients with lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma) Medizinische Universität Wien

MesaCapp: Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome (Phase 2) - AT Medizinische Universität Wien

Accelerated Corneal Cross-linking With Different Riboflavin Solutions (phase 3) Medizinische Universität Wien

PMR-SPARE: A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (phase 3) Medizinische Universität Wien

Correlation Between In-vivo Anatomy of Corneal Dystrophies as Assessed by High-Resolution Optical Coherence Tomography (OCT) Measurement and Histological Examination - A Pilot Study Medizinische Universität Wien

Treatment of Chronic Lymphocytic Leukemia With the Use of an Antiviral Compound - a Proof of Principle Study (Phase 4) Medizinische Universität Wien

Phase II Trial of Lenalidomide in Patients With Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT) Medizinische Universität Wien

Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease - The Vienna RAP Study (Phase 3) Medizinische Universität Wien

A Randomized, Placebo-Controlled, Double-Blind, Phase IIa Study of Amiloride in the Treatment of Acute Autoimmune Optic Neuritis Medizinische Universität Wien

A Randomized Double Blind Placebo Controlled Trial of Intranasal Submucosal Bevacizumab in Hereditary Hemorrhagic Telangiectasia (Phase 2) Medizinische Universität Wien

Effectiveness and safety of Dimethylfumarate in patients with Palmoplantar Pustulosis - a 24-week, open label, phase II trial Medizinische Universität Wien

Plerixafor for stem cell mobilization in patients with multiple myeloma who mobilize moderately to optimize collection results - a randomized, placebo-controlled, double-blind study (Phase 4) Medizinische Universität Wien

Very low doses of Rituximab for off-label treatment - a Pilot Trial (Phase 2) Medizinische Universität Wien

Induction of Cross-neutralizing Antibodies After Primary Vaccination With Two Different Tick-borne Encephalitis Virus Vaccines (Phase 4) Medizinische Universität Wien

An open, monocentric, uncontrolled phase 4 trial to characterise cellular and humoral immune responses following the first booster immunisation with the inactivated, purified Japanese Encephalitis vaccine IXIARO® in elderly compared to young individuals Medizinische Universität Wien

Safety, Tolerability and Efficacy of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Rejection After Kidney Transplantation - a Pilot Trial (Phase 2) - AT Medizinische Universität Wien

BORTEJECT: Bortezomib in Late Antibody-mediated Kidney Transplant Rejection (Phase 2) Medizinische Universität Wien

A randomized phase II pilot - trial, examining the safety, pharmacokinetics, pharmacodynamics, and clinical efficacy of escalating doses of alteplase in patients with acute lung injury / acute respiratory distress syndrome / severe pneumonia Medizinische Universität Wien

Efficacy of Lidocaine medicated plaster in patients with CRPS (complex regional pain syndrome): a pilot-study (phase 3) Medizinische Universität Wien

Long-term immunity after primary vaccination against tick-borne encephalitis in the elderly (phase 4) Medizinische Universität Wien

Comparison of Vaccination Routes: Subcutaneous Versus Intramuscular Application of FSME-Immun® (Phase 4) Medizinische Universität Wien

Application of FSME-IMMUN® in obese persons (phase 4) Medizinische Universität Wien

Application of FSME-Immun® in allergic patients (phase 4) Medizinische Universität Wien

Characterization of cellular and humoral immunity in the elderly upon vaccination with the purified inactivated Japanese Encephalitis Vaccine IXIARO® (phase 4) Medizinische Universität Wien

Neutralizing Antibody Titers 6 Years After the Third Dose of Inactivated Japanese Encephalitis Vaccine and Projected Duration of Protection (Phase 4) - AT Medizinische Universität Wien

NERIT: Neoadjuvante Radioimmuntherapie mit Cetuximab in Patienten mit fortgeschrittenen Tumoren der Kopf-Halsregion (Phase 2) Medizinische Universität Wien

HIPEC-Ovar: Feasibility of intraoperative hyperthermic intraperitoneal chemotherapy with carboplatin and paclitaxel in patients with advanced epithelial ovarian cancer - a combined phase I / II trial Medizinische Universität Wien

MTOR-INHIBITION-SARCOIDOSIS: Systems medicine analysis of sarcoidosis by targeting mTOR in a pilot study of sirolimus as treatment in patients with sarcoidosis (phase 2) Medizinische Universität Wien

A Collagen-Fibrin Patch (Tachosil®) for the Prevention of Symptomatic Lymphoceles after Pelvic Lymphadenectomy in Women with Gynecologic Malignancies: a Randomized Clinical Trial (Phase 3) - AT Medizinische Universität Wien

Pharmacokinetics of temozolomide in cerebrospinal fluid in children with malignant brain tumors (phase 1) Medizinische Universität Wien

TACTIQ (Treatment after Cervical Cancer with topical Imiquimod)-trial: Topical Imiquimod in Treating Patients with Persistent HPV-Infection after Surgical or Radiation Treatment of Cervical Cancer (Phase 2) Medizinische Universität Wien

Effects of Mannitol on Delayed Graft Function After Cadaveric Renal Transplantation (Phase 3) Medizinische Universität Wien

PACE ACE: Paclitaxel Plus Cetuximab for the Treatment of Recurrent and/or Metastatic Head and Neck Cancer After First-line Checkpoint Inhibitor Failure: A Multicenter, Single Arm Study (Phase 2) Medizinische Universität Wien

MEMMAT: A Phase II study of metronomic and targeted anti-angiogenesis therapy for children with recurrent/progressive medulloblastoma -ES Medizinische Universität Wien

Denosumab in the prevention of immobilization-induced bone loss in Intensive Care Unit patients (phase 3) Medizinische Universität Wien

A Phase 2a Multiple Dose "Basket Design" Study Of The Safety, Tolerability, And Pharmacologic Activity Of BT200 In Patients With Hereditary Bleeding Disorders Medizinische Universität Wien

MALT-IVA: A phase II trial of long-term intravenous treatment with bi-weekly Azithromycin in patients with gastric lymphoma of the mucosa associated lymphoid tissue (MALT-lymphoma) Medizinische Universität Wien

Oral Iloprost in pre-eclampsia treatment - a pilot study (phase 2) Medizinische Universität Wien

Safety, Tolerability and Efficacy of Monoclonal CD38 Antibody Felzartamab in Late Antibody-Mediated Renal Allograft Rejection - A Phase 2 Pilot Trial - AT Medizinische Universität Wien

Intraoperative Application of Nimodipine to the Facial and Cochlear Nerves During Vestibular Schwannoma Resection to Avoid Spasm-related Postoperative Facial Paralysis and Deafness - a Prospective Randomized Pilot Study (Phase 2) Medizinische Universität Wien

The FAB-HCC Trial: Fecal Microbiota Transplant (FMT) combined with Atezolizumab plus Bevacizumab in Patients with HepatoCellular Carcinoma who failed to respond to prior Immunotherapy - AT Medizinische Universität Wien

Pola_R: Efficacy of polatuzumab, bendamustine and rituximab in patients with relapsed/refractory mantle cell lymphoma - a single center phase II trial Medizinische Universität Wien

Triamcinolone Acetonide Levels in Cochlear Perilymph, Lateral Canal and CSF in Patients With Vestibular Schwannomas Medizinische Universität Wien

PIPLEVOLUNG: Pulmonary pharmacokinetics of piperacillin/tazobactam and levofloxacin in patients with chronic obstructive pulmonary disease or cystic fibrosis: Comparison of epithelial lining fluid, in-vivo microdialysis and tissue biopsy Medizinische Universität Wien

Intracochlear application versus round window instillation of Triamcinolone acetonide in patients with sudden sensorineural hearing loss - a comparative study Medizinische Universität Wien

An open-label, prospective, single-centre, phase II study to assess dose and dose interval requirements with respect to efficacy and safety of AOP2014, PEG-Proline-Interferon alpha-2b, in patients with primary myelofibrosis (grade MF-0 and MF-1)
Medizinische Universität Wien

MEMMAT: A Phase II study of metronomic and targeted anti-angiogenesis therapy for children with recurrent/progressive medulloblastoma - AT
Medizinische Universität Wien

Immunomodulation of Pembrolizumab Plus Docetaxel for the Treatment of Recurrent or Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (HNSCC) After Platinum Failure (Phase I-II)
Medizinische Universität Wien

O-MA 1: A Phase II trial of Ofatumumab in patients with lymphoma of the of the mucosa associated lymphoid tissue (MALT-Lymphoma)
Medizinische Universität Wien

Characterization of Humoral and Cellular Immunity for Tick-borne Encephalitis (TBE) Vaccination in Allogeneic Blood and Marrow Graft Recipients: a Pilot Study
Medizinische Universität Wien

MALT-A 1: A phase II trial of long-term treatment with azithromycin in patients with lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma)
Medizinische Universität Wien

MesaCapp: Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome (Phase 2) - AT
Medizinische Universität Wien

Accelerated Corneal Cross-linking With Different Riboflavin Solutions (phase 3)
Medizinische Universität Wien

PMR-SPARE: A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (phase 3)
Medizinische Universität Wien

Correlation Between In-vivo Anatomy of Corneal Dystrophies as Assessed by High-Resolution Optical Coherence Tomography (OCT) Measurement and Histological Examination - A Pilot Study
Medizinische Universität Wien

Treatment of Chronic Lymphocytic Leukemia With the Use of an Antiviral Compound - a Proof of Principle Study (Phase 4)
Medizinische Universität Wien

Phase II Trial of Lenalidomide in Patients With Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT)
Medizinische Universität Wien

Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease - The Vienna RAP Study (Phase 3)
Medizinische Universität Wien

A Randomized, Placebo-Controlled, Double-Blind, Phase IIa Study of Amiloride in the Treatment of Acute Autoimmune Optic Neuritis
Medizinische Universität Wien

A Randomized Double Blind Placebo Controlled Trial of Intranasal Submucosal Bevacizumab in Hereditary Hemorrhagic Telangiectasia (Phase 2)
Medizinische Universität Wien

Effectiveness and safety of Dimethylfumarate in patients with Palmoplantar Pustulosis - a 24-week, open label, phase II trial
Medizinische Universität Wien

Plerixafor for stem cell mobilization in patients with multiple myeloma who mobilize moderately to optimize collection results - a randomized, placebo-controlled, double-blind study (Phase 4)
Medizinische Universität Wien

Very low doses of Rituximab for off-label treatment - a Pilot Trial (Phase 2)
Medizinische Universität Wien

Induction of Cross-neutralizing Antibodies After Primary Vaccination With Two Different Tick-borne Encephalitis Virus Vaccines (Phase 4)
Medizinische Universität Wien

An open, monocentric, uncontrolled phase 4 trial to characterise cellular and humoral immune responses following the first booster immunisation with the inactivated, purified Japanese Encephalitis vaccine IXIARO® in elderly compared to young individuals
Medizinische Universität Wien

Safety, Tolerability and Efficacy of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Rejection After Kidney Transplantation - a Pilot Trial (Phase 2) - AT
Medizinische Universität Wien

BORTEJECT: Bortezomib in Late Antibody-mediated Kidney Transplant Rejection (Phase 2)
Medizinische Universität Wien

A randomized phase II pilot - trial, examining the safety, pharmacokinetics, pharmacodynamics, and clinical efficacy of escalating doses of alteplase in patients with acute lung injury / acute respiratory distress syndrome / severe pneumonia
Medizinische Universität Wien

Efficacy of Lidocaine medicated plaster in patients with CRPS (complex regional pain syndrome): a pilot-study (phase 3)
Medizinische Universität Wien

Long-term immunity after primary vaccination against tick-borne encephalitis in the elderly (phase 4)
Medizinische Universität Wien

Comparison of Vaccination Routes: Subcutaneous Versus Intramuscular Application of FSME-Immun® (Phase 4)
Medizinische Universität Wien

Application of FSME-IMMUN® in obese persons (phase 4)
Medizinische Universität Wien

Application of FSME-Immun® in allergic patients (phase 4)
Medizinische Universität Wien

Characterization of cellular and humoral immunity in the elderly upon vaccination with the purified inactivated Japanese Encephalitis Vaccine IXIARO® (phase 4)
Medizinische Universität Wien

Neutralizing Antibody Titers 6 Years After the Third Dose of Inactivated Japanese Encephalitis Vaccine and Projected Duration of Protection (Phase 4) - AT
Medizinische Universität Wien

NERIT: Neoadjuvante Radioimmuntherapie mit Cetuximab in Patienten mit fortgeschrittenen Tumoren der Kopf-Halsregion (Phase 2)
Medizinische Universität Wien

HIPEC-Ovar: Feasibility of intraoperative hyperthermic intraperitoneal chemotherapy with carboplatin and paclitaxel in patients with advanced epithelial ovarian cancer - a combined phase I / II trial
Medizinische Universität Wien

MTOR-INHIBITION-SARCOIDOSIS: Systems medicine analysis of sarcoidosis by targeting mTOR in a pilot study of sirolimus as treatment in patients with sarcoidosis (phase 2)
Medizinische Universität Wien

A Collagen-Fibrin Patch (Tachosil®) for the Prevention of Symptomatic Lymphoceles after Pelvic Lymphadenectomy in Women with Gynecologic Malignancies: a Randomized Clinical Trial (Phase 3) - AT
Medizinische Universität Wien

Pharmacokinetics of temozolomide in cerebrospinal fluid in children with malignant brain tumors (phase 1)
Medizinische Universität Wien

TACTIQ (Treatment after Cervical Cancer with topical Imiquimod)-trial: Topical Imiquimod in Treating Patients with Persistent HPV-Infection after Surgical or Radiation Treatment of Cervical Cancer (Phase 2)
Medizinische Universität Wien

Effects of Mannitol on Delayed Graft Function After Cadaveric Renal Transplantation (Phase 3)
Medizinische Universität Wien

PACE ACE: Paclitaxel Plus Cetuximab for the Treatment of Recurrent and/or Metastatic Head and Neck Cancer After First-line Checkpoint Inhibitor Failure: A Multicenter, Single Arm Study (Phase 2)
Medizinische Universität Wien

MEMMAT: A Phase II study of metronomic and targeted anti-angiogenesis therapy for children with recurrent/progressive medulloblastoma -ES
Medizinische Universität Wien

Denosumab in the prevention of immobilization-induced bone loss in Intensive Care Unit patients (phase 3)
Medizinische Universität Wien

A Phase 2a Multiple Dose "Basket Design" Study Of The Safety, Tolerability, And Pharmacologic Activity Of BT200 In Patients With Hereditary Bleeding Disorders
Medizinische Universität Wien

MALT-IVA: A phase II trial of long-term intravenous treatment with bi-weekly Azithromycin in patients with gastric lymphoma of the mucosa associated lymphoid tissue (MALT-lymphoma)
Medizinische Universität Wien

Oral Iloprost in pre-eclampsia treatment - a pilot study (phase 2)
Medizinische Universität Wien

Safety, Tolerability and Efficacy of Monoclonal CD38 Antibody Felzartamab in Late Antibody-Mediated Renal Allograft Rejection - A Phase 2 Pilot Trial - AT
Medizinische Universität Wien

Intraoperative Application of Nimodipine to the Facial and Cochlear Nerves During Vestibular Schwannoma Resection to Avoid Spasm-related Postoperative Facial Paralysis and Deafness - a Prospective Randomized Pilot Study (Phase 2)
Medizinische Universität Wien

The FAB-HCC Trial: Fecal Microbiota Transplant (FMT) combined with Atezolizumab plus Bevacizumab in Patients with HepatoCellular Carcinoma who failed to respond to prior Immunotherapy - AT
Medizinische Universität Wien

Pola_R: Efficacy of polatuzumab, bendamustine and rituximab in patients with relapsed/refractory mantle cell lymphoma - a single center phase II trial
Medizinische Universität Wien

Triamcinolone Acetonide Levels in Cochlear Perilymph, Lateral Canal and CSF in Patients With Vestibular Schwannomas
Medizinische Universität Wien

PIPLEVOLUNG: Pulmonary pharmacokinetics of piperacillin/tazobactam and levofloxacin in patients with chronic obstructive pulmonary disease or cystic fibrosis: Comparison of epithelial lining fluid, in-vivo microdialysis and tissue biopsy
Medizinische Universität Wien

Intracochlear application versus round window instillation of Triamcinolone acetonide in patients with sudden sensorineural hearing loss - a comparative study
Medizinische Universität Wien